BioCentury | Feb 20, 2012
Company News

Nanologica infectious, drug delivery news

...funding to the project. Members of ORCHID will research potential therapeutic areas including beta lactams, inhA enoyl-(acyl carrier protein) reductase...
BioCentury | Sep 8, 2008
Strategy

Getting real at TB alliance

...is thought to arise slowly. Other compounds GSK has in lead identification include inhibitors of inhA enoyl-(acyl carrier protein) reductase...
Items per page:
1 - 2 of 2